Barclays Forecasts Strong Price Appreciation for Illumina (NASDAQ:ILMN) Stock
Illumina (NASDAQ:ILMN – Free Report) had its price objective upped by Barclays from $77.00 to $85.00 in a report issued on Tuesday,Benzinga reports. They currently have an underweight rating on the life sciences company’s stock. Several other research analysts have also recently issued reports on the stock. Citigroup cut their target price on shares of […]
Illumina (NASDAQ:ILMN – Free Report) had its price objective upped by Barclays from $77.00 to $85.00 in a report issued on Tuesday,Benzinga reports. They currently have an underweight rating on the life sciences company’s stock. Several other research analysts have also recently issued reports on the stock. Citigroup cut their target price on shares of […]
